ProQuest Associates IV LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 49,854 shares at $85.10 ($4.2M) on 2016-11-10, disclosed to the SEC on 2016-11-14.
Open-market sale of $4.2M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.00 | 300 | $26K | 0.6% |
| 2 | $85.00 | 1,300 | $111K | 2.6% |
| 3 | $85.10 | 15,368 | $1.3M | 30.8% |
| 4 | $85.10 | 15,368 | $1.3M | 30.8% |
| 5 | $86.00 | 167 | $14K | 0.3% |
| 6 | $86.06 | 100 |
| $9K |
| 0.2% |
| 7 | $87.05 | 1,700 | $148K | 3.5% |
| 8 | $85.00 | 15,551 | $1.3M | 31.1% |
| Total | $85.14 avg | 49,854 | $4.2M | 100% |
| Filing → |
| EGRX | SELL | 2017-01-06 | $11.1M | — | Filing → |
| EGRX | SELL | 2016-11-04 | $21.0M | — | Filing → |
| EGRX | SELL | 2016-09-30 | $10.9M | — | Filing → |